The EAU Guidelines Office will provide a state-of-the-art update on male hypogonadism and testosterone replacement therapy. This recording will be of great educational value for urologists as internationally-known experts will focus on the controversial and challenging areas of this rapidly...
“The 2018 AUA guidelines for testosterone therapy that were co-chaired by Dr. John P. Mulhall say that we have an absence or a paucity of data on using testosterone therapy on active surveillance,” says Helen L. Bernie, DO, MPH...
https://www.urotoday.com/conference-highlights/aua-2024/aua-2024-prostate-cancer/151946-aua-2024-crossfire-controversies-in-urology-testosterone-therapy-may-be-reasonably-offered-to-men-on-active-surveillance-pro-con.html (UroToday.com) Recent developments in urology have increasingly...
Testosterone Treatment and the Risk of Prostate Adverse Events (2022) Jason A. Levy, DO, MS, Arthur L. Burnett, MD, MBA, Adrian S. Dobs, MD, MHS INTRODUCTION Definition Hypogonadism is a clinical syndrome that results from failure of the testis to produce physiologic concentrations of...
ABSTRACT Men with hypogonadism have reduced risk of prostate cancer mortality; whether testosterone treatment increases the risk of prostate safety events in men with hypogonadism remains controversial. Several studies including four larger randomized trials — the Testosterone Trials...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.